Annora Pharma Private Limited Efavirenz Export Data — India (DGFT 2022–2026)

Name: Annora Pharma Private Limited Efavirenz Export Records India — #15 Exporter, 12 Shipments, $208.6K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Efavirenz

India Pharmaceutical Trade Intelligence

$60.2M101 Suppliers121 CountriesHS 30049099

ExportsIndia → SOUTH AFRICA49.2%India → BELARUS7.1%

ImportsBELGIUM → India$10.1K UNITED KINGDOM → India$8.5K

Annora Pharma Private Limited — Efavirenz Exporter #15 | $208.6K Trade Value | TransData Nexus | TransData Nexus

Annora Pharma Private Limited — Efavirenz Exporter Profile

Indian Pharmaceutical Exporter · #15 for Efavirenz · $208.6K export value · DGFT Verified

Annora Pharma Private Limited is the #15 Indian exporter of Efavirenz with $208.6K in export value and 12 verified shipments. Annora Pharma Private Limited holds a 0.3% market share in Efavirenz exports across 1 countries. The company exports 13 pharmaceutical products worth $56.8M across 9 therapeutic categories.

Annora Pharma Private Limited — Efavirenz Export Profile: Buyers & Destinations

Annora Pharma Private Limited Efavirenz export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Efavirenz?

Country	Value	Shipments	Share
MALAYSIA	$3.5M	83	22.7%
SOUTH AFRICA	$2.6M	53	17.2%
UNITED STATES	$2.0M	52	12.9%
MYANMAR	$1.4M	42	9.0%

Who Are the Top Buyers of Efavirenz from India?

Buyer	Country	Value	Orders
PAHANG PHARMACY SDN BHD,	MALAYSIA	$1.7M	35
MACLEODS PHARMACEUTICALS SA	SOUTH AFRICA	$1.3M	25
PAHANG PHARMACY SDN BHD	MALAYSIA	$1.1M	22
VIATRIS HEALTHCARE (PTY) LTD,	SOUTH AFRICA	$400.0K	8
UNDP UZBEKISTAN	UZBEKISTAN	$400.0K	8
CIPLA USA INC UPS SUPPLY CHAIN SOLU	UNITED STATES	$250.0K	5
GLENMARK PHARMACEUTICALS EUROPE LTD	UNITED KINGDOM	$200.0K	4
STATE ENTERPRISE ACADEMPHARM	BELARUS	$150.0K	3
NATIONAL EMERGENCY RESPONSE COUNCIL HIV	SOUTH AFRICA	$150.0K	3
ICU VITA	URUGUAY	$100.0K	2

India's Efavirenz is purchased by 361 buyers worldwide. The top buyer is PAHANG PHARMACY SDN BHD, (MALAYSIA), followed by MACLEODS PHARMACEUTICALS SA and PAHANG PHARMACY SDN BHD.

How Does Annora Pharma Private Limited Compare to Nearest Efavirenz Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
13	EMCURE PHARMACEUTICALS LIMITED	$255.1K	9	3	$28.3K
14	SUN PHARMACEUTICAL INDUSTRIES LIMITED	$253.3K	12	7	$21.1K
15	ANNORA PHARMA PRIVATE LIMITED ★	$208.6K	12	1	$17.4K

Annora Pharma Private Limited ranks #15 among 101 Indian Efavirenz exporters. Average shipment value of $17.4K compared to the market average of $264.0K. The closest competitors by value are EMCURE PHARMACEUTICALS LIMITED and SUN PHARMACEUTICAL INDUSTRIES LIMITED.

Which Indian Ports Ship Efavirenz Exports?

Port	Shipments	% Share
SAHAR AIR	244	22.5%
SAHAR AIR CARGO ACC (INBOM4)	196	18.1%
Bombay Air	89	8.2%
DELHI AIR CARGO ACC (INDEL4)	73	6.7%
DELHI AIR	64	5.9%
NHAVA SHEVA SEA (INNSA1)	57	5.3%
JNPT/ NHAVA SHEVA SEA	43	4.0%
BANGALORE ACC (INBLR4)	30	2.8%

Geopolitical & Trade Policy Impact on Annora Pharma Private Limited's Efavirenz Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Annora Pharma. The Israel-Iran conflict has led to disruptions in the Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. These changes have resulted in increased lead times and freight costs, disproportionately affecting time-sensitive pharmaceutical shipments. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. (fortuneindia.com)

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. With the U.S. imposing tariffs on Chinese goods, Indian exporters have an opportunity to capture a larger share of the American market. However, this advantage is tempered by the U.S. administration's pressure on pharmaceutical companies to lower drug prices and the potential for increased tariffs on imported pharmaceuticals, which could impact profit margins. (lemonde.fr)

In the European Union, the implementation of the Falsified Medicines Directive (FMD) has introduced stringent regulations aimed at preventing counterfeit drugs from entering the supply chain. Compliance with these regulations requires significant investment in serialization and traceability systems. For companies like Annora Pharma, adhering to these standards is crucial to maintain access to the lucrative EU market.

Annora Pharma Private Limited — Regulatory Compliance & Quality Standards

Regulatory compliance remains a critical factor for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has intensified inspections of Indian manufacturing facilities, with over 200 inspections conducted in 2023 and plans to increase this number in 2024. Non-compliance can lead to warning letters, import alerts, and bans, severely impacting export capabilities. (fact.net.in)

Annora Pharma's involvement in a patent infringement lawsuit with BioCryst Pharmaceuticals highlights the importance of navigating intellectual property rights carefully. Ensuring that generic products do not infringe on existing patents is essential to avoid legal disputes that can delay market entry and result in financial liabilities.

Maintaining high-quality standards and adhering to Good Manufacturing Practices (GMP) are imperative for sustaining credibility and competitiveness in international markets. Investing in robust quality control systems and staying abreast of evolving regulatory requirements will be key for Annora Pharma's continued success.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Efavirenz shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Annora Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 121+ countries, 361+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Efavirenz

Efavirenz

Annora Pharma Private Limited — Efavirenz Exporter Profile

Annora Pharma Private Limited — Efavirenz Export Profile: Buyers & Destinations

Where Does India Export Efavirenz?

Who Are the Top Buyers of Efavirenz from India?

What Is India's Total Efavirenz Export Value and How Much Does Annora Pharma Private Limited Contribute?

What Is the Average Shipment Value for Annora Pharma Private Limited's Efavirenz Exports?

How Does Annora Pharma Private Limited Compare to Other Indian Efavirenz Exporters?

Regulatory Requirements: Exporting Efavirenz to Key Markets

South Africa — SAHPRA

United States — FDA

How Does Annora Pharma Private Limited Compare to Nearest Efavirenz Exporters?

Which Indian Ports Ship Efavirenz Exports?

Geopolitical & Trade Policy Impact on Annora Pharma Private Limited's Efavirenz Exports

Annora Pharma Private Limited — Regulatory Compliance & Quality Standards

About Annora Pharma Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Efavirenz Export Data from Annora Pharma Private Limited

Efavirenz Stats

Company Overview

Top Products by Annora Pharma Private Limited

Related Analysis

Need Detailed Export Data?

Data Source